Replies to post #112451 on Anavex Life Sciences Corp (AVXL)

[F1ash]

But this is an inconsequential typo. The real story of Anavex 2-73 is shown on slide 26.

No other drug, with Anavex 2-73's concomitant safety profile (see slide 24), has ever achieved such results for Alzheimer’s victims.

Wow that's an amazing looking graph.

Represents 53 weeks of results?

Are those results representative of all 32 patients?

Were there dropouts during those 53 weeks?

How did they represent those patients data in the graph if any did indeed drop out of the trial before 53 weeks?

It's an amazing looking graph, I'll agree.